Market regulation · 27/06/2005Updated: 10/17/2026 · 1 min read
FDA Lifts Stay on Lidoderm Patch Packaging Requirements
Summary
The US FDA has lifted a stay on enforcement of special packaging requirements for the prescription pain reliever Lidoderm Patch, allowing the manufacturer to resume compliance with the regulations.
Original source language: Federal Register — Consumer Product Safety CommissionOpen original release →